chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Tested positive for Covid; This spontaneous case was reported by a pharmacist and describes the occurrence of COVID-19 (Tested positive for Covid) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Tested positive for Covid). At the time of the report, COVID-19 (Tested positive for Covid) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided.  Patient got the 1st dose of the Moderna COVID-19 Vaccine and tested positive for COVID 3 days later. The patient was exposed to COVID at work & also had family members who tested positive around that time. The patient received monoclonal antibodies as treatment for COVID.; Sender's Comments: This case concerns a 45-year-old, female patient, with no disclosed medical history but with exposure to Covid at work and with family member, who experienced the non-serious, unexpected, AESI  event of Covid-19. The event occurred 3 days after first Moderna vaccine. The rechallenge is not applicable as patient only received first dose. The patient's exposure to Covid-19 and only one dose of vaccine received remain as confounders to the event. The benefit-risk relationship of Moderna vaccine is not affected by this report.
pt recv vax 27OCT97 & same day pt exp n/v;1NOV97 pt exp aches & pans w/a fever of 101-102, flank pain, lower extremity swelling, groin & auxiliary lymph node swelling;
Client received her first dose of the Pfizer Covid-19 vaccine (Lot # EW0187 Exp. 08/2021) on 6/3/21 at 2:48 PM. Client's husband whistled to EMT and paramedic, signaling that he needed assistance. Client was a 36-year-old female found sitting upright in an observation chair, alert and tracking and appeared to be in mild distress. Client had a chief complaint of throat irritation. Client's husband stated that the client was complaining of itchiness in her throat and on her chest. Client stated that she had a history of heart murmurs and frequent anxiety. Client denied prescription medication. Client had no known allergies. Assessment revealed no hives, swelling, discoloration, rash, accessory muscle use or other signs of anaphylaxis. Client stated that she began to feel the itchiness in her throat immediately after she received her shot but was hesitant to signal for assistance and waited a few minutes to notify staff. Client then added that her throat felt "swollen" and that she felt an itch on her chest as well. However, the client was able to make these statements without difficulty other than some mild fatigue. Airway, breathing and circulation were intact. Client was alert and oriented to person, place, date and event. Clients first set of vitals at 1503 were heart rate 138, respirations 28, blood pressure 152/98, O2 saturation 100% on room air, eyes equal and reactive to light, lung sounds clear bilaterally, and skin signs were normal throughout her body. Client was assisted from the observation chair to an observation bed by her husband and EMT. After lying down, the client briefly fell asleep and was laid supine. Client was asleep for approximately a minute before waking up. The client was then sat up and her vitals were retaken and had improved with a blood pressure of 138/98, heart rate 88, respirations 24 and O2 sat at 100%. After some brief monitoring, the client consented to an RN?s administration of Benadryl 50mg (Lot # 020020 Exp. 02/2022) Intramuscular at 1512 on her right arm. Client then remained lying down and stated that she felt "better" approximately 10 minutes after Benadryl administration. However, five minutes later the client complained of a headache and chest pain which she later described as itchiness on her chest once again. Client then briefly became extremely anxious again before becoming calmer and consenting to staff dialing 911. Client consented to 911 at 1522 and Paramedics arrived at 1530. Client's vitals were assessed at five minute intervals until paramedics arrived: 138/100 (BP), 112 (HR), 99% (O2), 24 (RR);  1512 - 138/100 (BP), 88 (HR), 100% (O2), 20 (RR), 1517 - 130/92, 76, 100%, 20, 1522 - 128/94, 76, 99%, 20, 1524 (Anxiety episode)- 158/98, 92, 100%, 28  1529 - 130/ 98, 76, 99%, 24. Client consented to transport with paramedics at 1540 to the nearest hospital.
In November of 2022, I developed back pain if I stood still for more than ten minutes. If I stood still for more than ten minutes, I would get a sciatica type pain starting in my left buttock. The pain would go away instantly as soon as I started moving. I could do all other activities, even running. The pain continued for several weeks. I called my doctor who performed an x-ray and prescribed physical therapy. The x-ray showed degenerative disc disease in my lumbar. I did physical therapy twice. The day after my second physical therapy, I was doing my stretches and exercises at home. However, the next morning, I couldn't move. I couldn't lay down or walk more than a few steps. All I could do was sit in a leaning forward position. On 12/25/2022, I went to the emergency room where they did an MRI which showed a disc protrusion on L5 and S1. It was hitting the L5 nerve which was most likely causing my pain. There were a couple of discs above that were bulging as well, but it was the disc protrusion that was most severe. They prescribed a six-day course of steroids which didn't do anything. They also prescribed a muscle relaxer which also didn't help. They then started me on a ten-day steroid pack. I went back to the emergency room on 1/12/2023 because the pain had gotten so bad that I couldn't even take a few steps. They were trying to manage the pain with oxycodone, PERCOCET, and TYLENOL. The only thing that ended up working was morphine, so they put me on a morphine pump. Because my only symptoms were pain, I was not a candidate for emergency surgery, I had to wait until 01/03/2023. In the meantime, my legs became very swollen due to not being able to move. My legs started to blister, and I developed large blisters on the top of my feet. I was finally able to go in for surgery, but they were worried about the blisters, so they lanced them. However, they filled up again, so they had to open them up and I had open wounds on my legs. They addressed that and took me to surgery. They did a laminotomy on L4 and L5 as well as a microdiscectomy and a fusion on L5 and S1. At the same time, when I was in the hospital on 01/12/2023, I was in atrial fibrillation, so they are trying to manage that. They were able to get my heart rate down which was up to 150 beats a minute or higher. They couldn't get me out of atrial fibrillation, but they were able to treat my heart rate with metoprolol. After surgery, the atrial fibrillation went away for a few days but came back with RVR. It didn't last long, but they were concerned I might be getting blood clots. They did a CT scan with dye and found that I did have blood clots which were already in my lungs. I had pulmonary embolism in both lungs, but I was asymptomatic. I was not having difficulty breathing or anything which the doctors found unusual. They put me on blood thinners and kept me in the hospital for observation. The atrial fibrillation went away again so they released me from the hospital on 01/31/2023 and prescribed LOVENOX injections. They are going to switch me to an ELIQUIS prescription, and I have multiple follow ups with varying doctors.
no adverse event; HCP reporting an improperly stored vaccine was administered to a patient. No additional details provided. No additional AE. No PQC.   ?    Names of vaccines involved: PROQUAD (Lot: W019623, Expiration Date: 19DEC2023) ?    Temperature: -11.8C ?; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 13-SEP-2022, the patient was vaccinated with inappropriately stored dose (temperature: -11.8 Celsius degrees, time frame: 1 h 45 min 0 sec), no previous temperature excursion) of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (rHA) subcutaneous injection, lot number W019623, expiration date: 19-DEC-2023, administered for prophylaxis (dose, strength, and route of administration were not provided) (product storage error). No additional adverse event was reported (no adverse event).
Woke up the next morning with a fever, and I felt nauseous and light-headed for the rest of the day
Pt had been to PCP on 11/8/01 for a check-up and she was healthy, no medical problems and blood work was normal. She was found on 11/13/01 per housekeeper on the floor. MD signed the death certificate as "atrial fib" but said COD was either heart attach or CVA. No autopsy done. Actual death certificate states cause of death as ventricular fibrillation due to coronary artery disease.
Patient presented to me 24-48h s/p pharmacy flu vaccine administration into the (L) lateral tricep. Area of cellulitis around injection site, treated with abx. Incorrect administration and likely poor sterile technique.
Pt has redness at site of shot but states that this is normal for every shot that she receieves (steroid, flu shots) however, pt also stated that she had some difficulty breathing the first 2 days (day of and day after receiving the vaccine) she states that this has pretty must resolved but the Dr is following up.
Within an hour of getting the vaccine the left side of my face began to tingle and feel numb. The sensation traveled from my jaw bone to my forehead but at all times limited to the left side of my face.  The sensation affected the area of my ear nd behind the ear. The sensation affected the left side of my nose and left cheekbone. I Within minutes of these symptons i took a 25 mg benedryl pii and I followed it up with another 25 mg 5 minutes later. It was only then that I started to feel some relief.  I didnt feel any swelling of tongue or lips and my breathing was unaffected.  My skin felt numb.  I compare it to the feeling one gets after novacane starts to wear off after dental work.  I called Dr right away and told them what was happening and that I had taken benedryl. Although I feel mucgh better I still have tingling sensation on the left side of my face.  I attempted to see my dr. today but his office directed that I first submit this report.
He got his vaccine, then around 6:00 PM he felt very cold, chilled.  Then he had body shakes, fatigue, sleepy.  Then he covered up with blankets and slept for about an hour.  Then he got up and was hot.  When he went to sleep at night he had chest pains on the right side of his heart.  He had to keep swinging his arms in circles to get relief of that pain.  He felt a lot of heat coming out of his body.  Then he had a headache, painful in the back of his head that lasted for more than half of the month.  He was not comfortable to go into the public so did not seek any medical attention.  He has never had any headaches before and now he has them that come and go and attributes this to the vaccine that he received.  He did not take anything to relief his headaches as he does not like to take drugs.   The chest pain lasted for about a week, but the headaches again come and go.
headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (headache). At the time of the report, HEADACHE (headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Relevant concomitant medications were not reported.  The treatment information was  not provided.    This case was linked to US-MODERNATX, INC.-MOD-2021-100553 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-100553:
Itching on upper torso, face, and scalp; Rapid heartbeat; Tight throat; Dizziness; Nausea; injection site pain; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: Er8733) via an unspecified route of administration in the left arm on 09Apr2021 at 10:45 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and allergies. The patient received unspecified medications within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: En6208) via an unspecified route of administration in the left arm on 15Mar2021 at 10:00 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. The patient had unspecified allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 10:45, the patient experienced Itching on upper torso, face, and scalp, rapid heartbeat,  tight throat, dizziness, nausea and injection site pain. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken for the reported events and included treatment with Benadryl. The clinical outcome of the events Itching on upper torso, face, and scalp, rapid heartbeat, tight throat, dizziness, nausea and injection site pain were recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Patient was seen in office. While here it was suggested that patient get PREVNAR. Patient agreed, but forgot he had this in 12/19/14. Also CMA did not check documentation.
unspecified rash, redness, pain, tenderness and swelling from the deltoid to the elbow; unspecified rash, redness, pain, tenderness and swelling from the deltoid to the elbow; unspecified rash, redness, pain, tenderness and swelling from the deltoid to the elbow; unspecified rash, redness, pain, tenderness and swelling from the deltoid to the elbow; unspecified rash, redness, pain, tenderness and swelling from the deltoid to the elbow; This spontaneous report was received from a nurse referring to a female patient of unknown age with drug reactions/allergies to nonsteroidal anti-inflammatory drug (NSAIDS), penicillin and sulfacetamide sodium (+) sulfadiazine (+) sulfamethazine (SULFA). There was no concomitant medication.     On 04-AUG-2020, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (strength and dose were unknown; lot # S036495, expiration date 13-SEP-2021) via intramuscular route for prophylaxis.        A few hours later, the patient experienced an unspecified rash, redness, pain, tenderness and swelling from the deltoid to the elbow. Symptoms worsened overnight. On 05-AUG-2020, the patient had a telehealth visit with physician and was prescribed acetaminophen (TYLENOL) and diphenhydramine hydrochloride (BENADRYL). No lab diagnostics/studies were performed. Symptoms were not resolved. The causality assessment was not provided.  The reporter requested a lot check for pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23)  lot S036495, expiration date 13-SEP-2021. combinationproductreport: Yes; brandname: PNEUMOVAX23 SYRINGE (DEVICE); commondevicename: Pneumococcal Vaccine, Polyvalent (23-valent); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp; devicelotnumber: S036495; expirationdate: 13-SEP-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Unknown; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not suggest a causal association with the device or device constituent
Still got Covid-19; Still got Covid-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID. The reporter is the patient.  A male patient (age 19 unit not reported) received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "Still got Covid-19".  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
took the shots a couple of months before, he came down with them/suspected vaccination failure; took the shots a couple of months before he came down with them.; This case was reported by a consumer and described the occurrence of suspected vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine and the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.  Additional details were provided as follows: Age at vaccination was not reported. The case was reported by the patient for himself. The patient took the Shingles shots a couple of months before, he came down with them. This case was considered as suspected vaccination failure since details regarding time to onset and laboratory test confirming shingles were not provided.
COVID-19 PCR test positive; they had a sore arm that day that went away with no side effects.; This is a spontaneous report from a Pfizer sponsored program. A contactable consumer (patient) reported that a 50-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: ER8732) via an unspecified route of administration on 08Apr2021 at 07:00 pm on left arm as 1st dose, single dose for COVID-19 immunization. The medical history and concomitant medications were not reported. The patient reported that three out of four of her family got the first dose of the vaccine then tested positive for COVID-19 on 20Apr2021. Her husband went in related to his allergies to get tested. She says it was her mother-in-law that had passed, then Tuesday they all got tested and they were all negative. She says her husband started feeling like he had allergies Friday after he cut the grass, and her son is a crazy person about COVID, but he has asthma so he wanted them to all get tested again since allergies can be like COVID, and her husband's test was positive, so then she and her son got tested and they were positive, so they had three positives out of the four family members who got the first dose. She clarifies that her mother-in-law didn't get the vaccine, but she had passed away Tuesday, and they contracted COVID during that time after she passed away at home. They had not gotten any other vaccinations the day of the first dose of the COVID-19 vaccine or in the four weeks prior. Their second dose is scheduled on 29Apr2021, he would like to know if they need to get tested and test negative for Covid-19 before receiving the second dose of the vaccine. They told her May 4th was when they could get their second dose after quarantining. She says that they were all fine after they got the first dose of the vaccine, they had a sore arm that day that went away with no side effects. She says that her arm soreness began that night into the next day, then it went away without treatment the next day after that, so lasting about 24 hours. She says she felt like if she had been able to move her arm after instead of how she slept on it at night, it would have been less, but she didn't get to move it around much since they got it at night.   No follow-up attempts are needed. No further information is expected
PT REPORTS CHILLS, FEVER, NAUSEA NUGHTSWEATS THAT DISAPPEARED WITHIN THE FIRST 24 HOURS AFTER ADMINISTRATION. FATIGUE LASTED 48 HOURS. WITHIN 48 HOURS AFTER VACCINE ADMINISTRARTION PATIENT REPORTED FEELING LYMPH NODE SWELLING/JAW PAIN ON THE SIDE OF THE FACE. PT USED COLD COMPRESSES TO CONTROL THE SWELLING, THE SWEELING AND PAIN LASTED ONE WEEK UNTIL IT STARTED TO SUBSIDE.
had a flare up of Diverticulitis; This is a spontaneous report from a contactable consumer or other non-health care professional. A 26-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number and Expiration date was not reported), via an unspecified route of administration on 25Apr2021 as dose 1, single for COVID-19 immunisation. The patient medical history and concomitant medications of the patient were not reported. It was reported that the patient received Pfizer covid vaccine on 25Apr2021 and had a flare up of Diverticulitis, her HCP told her to postpone getting the second dose. It had been 3 months since postponed second dose of Pfizer covid vaccine. Reporter wants to know was it ok to receive second dose of Pfizer covid vaccine then due to the time and asked if she could receive HPV vaccine and the Pfizer covid vaccine or would she had to wait. The outcome of event was Unknown.  Information about lot/batch number has been requested.